Gary E Raskob

4PUBLICATIONS
20CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 07, 2022
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.

Gary E Raskob, Walter Ageno, Gregory Albers

|Jul 13, 2022
Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population.

Gary E Raskob, Aaron M Wendelboe, Janis Campbell

|Nov 10, 2021
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.

Gary E Raskob, Alex C Spyropoulos, Theodore E Spiro

Pageof 1